Alzheimer Disease: From Molecular Biology to TheraphySpringer Science & Business Media, 1. pro 1996. - Broj stranica: 614 This volume reviews the new potential treatments and research in the area of Alzheimer's disease. Special attention is given to international developments in all fields relevant to new drug development. Topics discussed include: progress in the international harmonization of drug development guidelines for dementia drugs; bioethics and law; development of rating instruments; behavioural treatments; and the activities of the Reagan Foundation. The text integrates basic and clinical research findings, and provides evaluation of new approaches to therapy by world leaders in the field. The potential benefit for Alzheimer patients and families resulting from these research programmes, from molecular biology to clinical pharmacology, is reviewed and evaluated. |
Sadržaj
I | 3 |
II | 7 |
III | 13 |
IV | 19 |
V | 25 |
VI | 31 |
VII | 37 |
VIII | 47 |
XLVIII | 323 |
XLIX | 329 |
L | 337 |
LI | 343 |
LII | 349 |
LIII | 355 |
LIV | 361 |
LV | 367 |
IX | 55 |
X | 61 |
XI | 67 |
XII | 75 |
XIII | 81 |
XIV | 87 |
XV | 91 |
XVI | 99 |
XVII | 107 |
XVIII | 113 |
XIX | 119 |
XX | 125 |
XXI | 133 |
XXII | 137 |
XXIII | 145 |
XXIV | 153 |
XXV | 159 |
XXVI | 165 |
XXVII | 171 |
XXVIII | 179 |
XXIX | 187 |
XXX | 205 |
XXXI | 211 |
XXXII | 217 |
XXXIII | 223 |
XXXIV | 231 |
XXXV | 239 |
XXXVI | 245 |
XXXVII | 251 |
XXXVIII | 257 |
XXXIX | 269 |
XL | 275 |
XLI | 281 |
XLII | 287 |
XLIII | 293 |
XLIV | 299 |
XLV | 305 |
XLVI | 311 |
XLVII | 317 |
LVI | 375 |
LVII | 381 |
LVIII | 387 |
LIX | 393 |
LX | 399 |
LXI | 407 |
LXII | 413 |
LXIII | 419 |
LXIV | 425 |
LXV | 431 |
LXVI | 435 |
LXVII | 439 |
LXVIII | 445 |
LXIX | 451 |
LXX | 457 |
LXXI | 463 |
LXXII | 469 |
LXXIII | 475 |
LXXIV | 481 |
LXXV | 487 |
LXXVI | 495 |
LXXVII | 501 |
LXXVIII | 507 |
LXXIX | 513 |
LXXX | 521 |
LXXXI | 529 |
LXXXII | 535 |
LXXXIII | 541 |
LXXXIV | 549 |
LXXXV | 555 |
LXXXVI | 561 |
LXXXVII | 567 |
LXXXVIII | 573 |
LXXXIX | 579 |
XC | 585 |
XCI | 591 |
599 | |
609 | |
Ostala izdanja - Prikaži sve
Alzheimer Disease: From Molecular Biology to Theraphy Robert Becker,Ezio Giacobini Ograničeni pregled - 2012 |
Alzheimer Disease: From Molecular Biology to Theraphy Robert Becker,Ezio Giacobini Pregled nije dostupan - 2012 |
Uobičajeni izrazi i fraze
1996 Birkhäuser Boston acetylcholine acetylcholinesterase AChE inhibitors activity ADAS-Cog agonists allele Alzheimer disease Alzheimer's disease amyloid precursor protein ApoE apolipoprotein Aẞ assessment B-amyloid basal forebrain baseline Becker behavioral binding Brain Res Cacabelos caregivers CDP-Choline cells CERAD cerebral cerebral cortex choline cholinergic cholinesterase inhibitors clinical trials compounds correlation cortex cortical decrease deficits demented dementia diagnosis disorders dose drug effects efficacy elderly enzyme eptastigmine evaluation factor free radicals function Giacobini 1996 Birkhäuser hippocampal human improvement increased induced inhibition interaction lesions levels measures memory metabolism metrifonate mg/kg mice microtubule MMSE muscarinic agonists nAChR Natl Acad Sci Neurochem neurodegeneration neurofibrillary tangles Neurology neurons neuropathological Neurosci nicotine patients peptide Pharmacol pharmacological phosphorylation physostigmine placebo plaques potential Proc Natl Acad progression propentofylline scale scores selegiline senile significant studies subjects symptoms synaptic tacrine therapeutic therapy transgenic treatment vascular vitro vivo Wisniewski